Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Can We Deal with Learning Curves in Acute Stroke?

When an interventional cardiology center, where interventional cardiology specialists work alongside neurologists and radiologists, start a thrombectomy program in acute stroke, results achieved are similar to those at an interventional neurology center.

¿Podemos afrontar la curva de aprendizaje en el stroke agudo?

Mechanical thrombectomy has proven to be the best treatment option for acute ischemic stroke. However, it is not widely available, mainly due to logistic difficulties.

An endovascular treatment program for acute stroke was initiated in 2012 at a cardiac cath lab.

The decision to perform the procedure was taken by neurologists based on symptoms and tomographic findings. The primary endpoint was functional result (Modified Rankin Scale score) of patients 3 months after the procedure.

From the beginning of the program in 2012 until the end of enrollment in 2019, 333 patients were treated.

Clinical results did not change significantly during this period of time and almost half the population achieved a modified Rankin Scale score of 0-2 (47.9%).

Symptomatic intracerebral hemorrhage was observed in 5.7% of patients, while embolization of new vascular territory was informed in 1.8%.


Read also: Experts Reach Consensus on Post TAVR Pacemaker Indication.


The clinical results were as desired from the beginning of the program without the effect of a learning curve.

These data support the potential for interventional cardiologists to treat acute stroke in regions where therapy is not available due to a lack of interventional neurologists.

Conclusion

An interventional cardiology center with experienced staff working as a team with neurologists and radiologists can begin an endovascular treatment program for acute stroke with results comparable to those of a center with interventional neurologists. These results can be obtained from the start without a learning curve.

Original Title: Stable Clinical Outcomes When a Stroke Thrombectomy Program Is Started in an Experienced Cardiology Cath Lab.

Reference: Jakub Sulženko et al. JACC Cardiovasc Interv. 2021 Apr 12;14(7):785-792. doi: 10.1016/j.jcin.2021.01.025.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

C-TRACT: Endovascular therapy in post-thrombotic syndrome due to iliac obstruction

Post-thrombotic syndrome (PTS) is one of the most limiting sequelae following proximal deep vein thrombosis (DVT). It clinically manifests as chronic pain, edema, skin...

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...